Growth Metrics

Neurocrine Biosciences (NBIX) Shares Outstanding (Diluted Average): 2009-2020

Historic Shares Outstanding (Diluted Average) for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $97.8 million.

  • Neurocrine Biosciences' Shares Outstanding (Diluted Average) fell 0.10% to $97.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $97.9 million, marking a year-over-year decrease of 0.10%. This contributed to the annual value of $97.8 million for FY2020, which is 0.62% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Shares Outstanding (Diluted Average) stood at $97.8 million for FY2020, which was up 0.62% from $97.2 million recorded in FY2019.
  • Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) peaked at $97.8 million during FY2020, and registered a low of $86.7 million during FY2016.
  • In the last 3 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) had a median value of $97.2 million in 2019 and averaged $96.8 million.
  • Data for Neurocrine Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 6.86% (in 2017) over the last 5 years.
  • Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) (Yearly) stood at $86.7 million in 2016, then increased by 6.86% to $92.7 million in 2017, then rose by 2.96% to $95.4 million in 2018, then climbed by 1.89% to $97.2 million in 2019, then increased by 0.62% to $97.8 million in 2020.